Clinical Trials
564
Active:14
Completed:279
Trial Phases
5 Phases
Phase 1:20
Phase 2:40
Phase 3:28
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (467 trials with phase data)• Click on a phase to view related trials
Not Applicable
328 (70.2%)Phase 4
51 (10.9%)Phase 2
40 (8.6%)Phase 3
28 (6.0%)Phase 1
20 (4.3%)TREATMENT OF VAGINAL DRYNESS IN PRIMARY SJÖGREN'S DISEASE WITH CO2-LASER VERSUS TOPICAL PROMESTRIENE
Not Applicable
Not yet recruiting
- Conditions
- Sjogren Syndrome
- Interventions
- Device: Fractional CO2 laser (vaginal)
- First Posted Date
- 2025-09-03
- Last Posted Date
- 2025-09-03
- Lead Sponsor
- University of Sao Paulo General Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT07153276
Evaluation by Clinical and Hand Ultrasound in Carpal Tunnel Syndrome
Recruiting
- Conditions
- Carpal Tunnel Syndrome (CTS)Carpal Tunnel Surgery
- First Posted Date
- 2025-08-21
- Last Posted Date
- 2025-08-28
- Lead Sponsor
- University of Sao Paulo General Hospital
- Target Recruit Count
- 106
- Registration Number
- NCT07134361
- Locations
- 🇧🇷
Instituto de Ortopedia e Traumatologia do Hospital das Clínicas da FMUSP, São Paulo, São Paulo, Brazil
Validation of a Patient Knowledge Questionnaire for Pulmonary Hypertension
Not Applicable
Not yet recruiting
- Conditions
- Pulmonary Arterial Hypertension (PAH)Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)Pulmonary Hypertension
- First Posted Date
- 2025-08-13
- Last Posted Date
- 2025-08-13
- Lead Sponsor
- University of Sao Paulo General Hospital
- Target Recruit Count
- 215
- Registration Number
- NCT07120789
- Locations
- 🇧🇷
Instituto do Coração (InCor), Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil
Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
Not Applicable
Not yet recruiting
- Conditions
- Rheumatoid Arthritis (RA)Juvenile Idiopathic Arthritis (JIA)Systemic Lupus Erythematosus (SLE)Juvenile Systemic Lupus ErythematosusSjögren's DiseaseSystemic Sclerosis (SSc)Idiopathic Inflammatory Myopathies (IIMs)Axial SpondyloarthritisPsoriatic Arthritis (PsA)Granulomatosis With Polyangiitis
- Interventions
- First Posted Date
- 2025-07-28
- Last Posted Date
- 2025-09-24
- Lead Sponsor
- University of Sao Paulo General Hospital
- Target Recruit Count
- 477
- Registration Number
- NCT07087912
- Locations
- 🇧🇷
Hospital das Clínicas da Faculdade de Medicina da USP, São Paulo, São Paulo, Brazil
🇧🇷Rheumatology Division, Faculdade de Medicina da USP, São Paulo, São Paulo, Brazil
Clinical Trial Phase I/IIa to Evaluate the Safety and Immunogenicity of StreptInCor
Not Applicable
Not yet recruiting
- Conditions
- Rheumatic Heart DiseaseRheumatic Heart Disease in ChildrenVaccine Adverse ReactionRheumatic DiseasesVaccine AcceptanceVaccine
- Interventions
- Other: PlaceboBiological: StrepIncor
- First Posted Date
- 2025-07-22
- Last Posted Date
- 2025-07-22
- Lead Sponsor
- University of Sao Paulo General Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT07078357
- Locations
- 🇧🇷
Heart Institute - Hospital Das Clinicas Da Faculdade de Medicina Da Universidade de São Paulo, São Paulo, SP, Brazil
- Prev
- 1
- 2
- 3
- 4
- 5
- 113
- Next
News
No news found